Myotonic dystrophy CTG expansion affects synaptic vesicle proteins, neurotransmission and mouse behaviour

Brain

Volumn 136, Issue 3, 2013, Pages 957-970

  Hernández Hernández, Oscar ^a,n   Guiraud Dogan, Céline ^a,b   Sicot, Géraldine ^a   Huguet, Aline ^a   Luilier, Sabrina ^c   Steidl, Esther ^d   Saenger, Stefanie ^e   Marciniak, Elodie ^f   Obriot, Hélène ^f   Chevarin, Caroline ^g   Nicole, Annie ^a   Revillod, Lucile ^b   Charizanis, Konstantinos ^h   Lee, Kuang Yung ^h,i   Suzuki, Yasuhiro ^j   Kimura, Takashi ^j   Matsuura, Tohru ^k   Cisneros, Bulmaro ^l   Swanson, Maurice S ^h   Trovero, Fabrice ^c   Buisson, Bruno ^d   Bizot, Jean Charles ^c   Hamon, Michel ^g   Humez, Sandrine ^f   Bassez, Guillaume ^b,m   Metzger, Friedrich ^e   Buée, Luc ^f   Munnich, Arnold ^a   Sergeant, Nicolas ^f   Gourdon, Geneviève ^a   Gomes Pereira, Mário ^a   more..

^a INSERM   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c Centre d'Innovation   (France)

^d Neuroservice   (France)

^e F HOFFMANN LA ROCHE LTD   (Switzerland)

^f UNIV LILLE   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

ⁱ CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^j National Hospital Organization Asahikawa Medical Center   (Japan)

^k OKAYAMA UNIVERSITY   (Japan)

^l DEPARTAMENTO DE FÍSICA   (Mexico)

^m UNIVERSITÉ PARIS EST CRÉTEIL   (France)

ⁿ DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

more..

Author keywords

myotonic dystrophy; RAB3A; synapsin I; synaptic transmission; transgenic mice

Indexed keywords

DOPAMINE; RAB PROTEIN; SEROTONIN; SYNAPSIN I;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BEHAVIOR DISORDER; COGNITION; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EXOCYTOSIS; HUMAN; HUMAN TISSUE; MOUSE; MYOTONIC DYSTROPHY; NERVE CELL PLASTICITY; NEUROSECRETION; NEUROTRANSMISSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFECT; SYNAPSE VESICLE; TRINUCLEOTIDE REPEAT; UPREGULATION;

EID: 84874916176     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws367     Document Type: Article

References (70)

1. Angeard N, Gargiulo M, Jacquette A, Radvanyi H, Eymard B, Heron D. Cognitive profile in childhood myotonic dystrophy type 1: is there a global impairment? Neuromuscul Disord 2007; 17: 451-8.
2. Arias-Carrion O, Poppel E. Dopamine, learning, and reward-seeking behavior. Acta Neurobiol Exp (Wars) 2007; 67: 481-8.
3. Bassez G, Chapoy E, Bastuji-Garin S, Radvanyi-Hoffman H, Authier FJ, Pellissier JF, et al. Type 2 myotonic dystrophy can be predicted by the combination of Type 2 muscle fiber central nucleation and scattered atrophy. J Neuropathol Exp Neurol 2008; 67: 319-25.
4. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992; 69: 799-808.
5. Bungener C, Jouvent R, Delaporte C. Psychopathological and emotional deficits in myotonic dystrophy. J Neurol Neurosurg Psychiatry 1998; 65: 353-6.
6. Charizanis K, Lee KY, Batra R, Goodwin M, Zhang C, Yuan Y, et al. Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron 2012; 75: 437-50.
7. Charlet BN, Savkur RS, Singh G, Philips AV, Grice EA, Cooper TA. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 2002; 10: 45-53.
8. Chiappalone M, Casagrande S, Tedesco M, Valtorta F, Baldelli P, Martinoia S, et al. Opposite changes in glutamatergic and GABAergic transmission underlie the diffuse hyperexcitability of synapsin I-deficient cortical networks. Cereb Cortex 2009; 19: 1422-39.
9. D'Adamo P, Wolfer DP, Kopp C, Tobler I, Toniolo D, Lipp HP. Mice deficient for the synaptic vesicle protein Rab3a show impaired spatial reversal learning and increased explorative activity but none of the behavioral changes shown by mice deficient for the Rab3a regulator Gdi1. Eur J Neurosci 2004; 19: 1895-905.
10. Delaporte C. Personality patterns in patients with myotonic dystrophy. Arch Neurol 1998; 55: 635-40.
11. Fdez E, Hilfiker S. Vesicle pools and synapsins: new insights into old enigmas. Brain Cell Biol 2006; 35: 107-15.
12. Fiorelli M, Duboc D, Mazoyer BM, Blin J, Eymard B, Fardeau M, et al. Decreased cerebral glucose utilization in myotonic dystrophy. Neurology 1992; 42: 91-4.
13. Fiumara F, Milanese C, Corradi A, Giovedi S, Leitinger G, Menegon A, et al. Phosphorylation of synapsin domain A is required for post-tetanic potentiation. J Cell Sci 2007; 120: 3228-37.
14. Fu YH, Pizzuti A, Fenwick RG Jr, King J, Rajnarayan S, Dunne PW, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992; 255: 1256-8.
15. Gambardella S, Rinaldi F, Lepore SM, Viola A, Loro E, Angelini C, et al. Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients. J Transl Med 2010; 8: 48.
16. Gaspar JM, Baptista FI, Galvao J, Castilho AF, Cunha RA, Ambrosio AF. Diabetes differentially affects the content of exocytotic proteins in hippocampal and retinal nerve terminals. Neuroscience 2010; 169: 1589-600.
17. Gaul C, Schmidt T, Windisch G, Wieser T, Muller T, Vielhaber S, et al. Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and Type 2 (DM2). Neurology 2006; 67: 350-2.
18. Geppert M, Goda Y, Stevens CF, Sudhof TC. The small GTP-binding protein Rab3A regulates a late step in synaptic vesicle fusion. Nature 1997; 387: 810-4.
19. Gomes-Pereira M, Foiry L, Nicole A, Huguet A, Junien C, Munnich A, et al. CTG trinucleotide repeat "big jumps": large expansions, small mice. PLoS Genet 2007; 3: e52.
20. Gomes-Pereira M, Monckton DG. Chemical modifiers of unstable expanded simple sequence repeats: what goes up, could come down. Mutat Res 2006; 598: 15-34.
21. Guiraud-Dogan C, Huguet A, Gomes-Pereira M, Brisson E, Bassez G, Junien C, et al. DM1 CTG expansions affect insulin receptor isoforms expression in various tissues of transgenic mice. Biochim Biophys Acta 2007; 1772: 1183-91.
22. Harper PS. Myotonic dystrophy. 3rd edn. London: WB Saunders; 2001.
23. Huguet A, Medja F, Nicole A, Vignaud A, Ferry A, Guiraud-Dogan C, et al. Molecular, physiological and motor performance defects in DMSXL mice carrying 41000 CTG repeat from the human DM1 locus. PLoS Genet London 2012; 8: e1003043.
24. Izac SM, Eeg TR. Basic anatomy and physiology of sleep. Am J Electroneurodiagnostic Technol 2006; 46: 18-38.
25. Jiang H, Mankodi A, Swanson MS, Moxley RT, Thornton CA. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Genet 2004; 13: 3079-88.
26. Kalsotra A, Xiao X, Ward AJ, Castle JC, Johnson JM, Burge CB, et al. A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc Natl Acad Sci USA 2008; 105: 20333-8.
27. Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, Esson D, et al. A muscleblind knockout model for myotonic dystrophy. Science 2003; 302: 1978-80.
28. Kuyumcu-Martinez NM, Wang GS, Cooper TA. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol Cell 2007; 28: 68-78.
29. Lee HW, Seo HS, Ha I, Chung SH. Overexpression of BACE1 stimulates spontaneous basal secretion in PC12 cells. Neurosci Lett 2007; 421: 178-83.
30. Lin X, Miller JW, Mankodi A, Kanadia RN, Yuan Y, Moxley RT, et al. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet 2006; 15: 2087-97.
31. Lueck JD, Lungu C, Mankodi A, Osborne RJ, Welle SL, Dirksen RT, et al. Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1. Am J Physiol Cell Physiol 2007; 292: C1291-7.
32. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 1992; 255: 1253-5.
33. Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, Moxley RT, et al. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 2002; 10: 35-44.
34. Masuda A, Andersen HS, Doktor TK, Okamoto T, Ito M, Andresen BS, et al. CUGBP1 and MBNL1 preferentially bind to 3' UTRs and facilitate mRNA decay. Sci Rep 2012; 2: 209.
35. Meola G, Sansone V. Cerebral involvement in myotonic dystrophies. Muscle Nerve 2007; 36: 294-306.
36. Meola G, Sansone V, Perani D, Colleluori A, Cappa S, Cotelli M, et al. Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy. Neurology 1999; 53: 1042-50.
37. Meola G, Sansone V, Perani D, Sáe S, Cappa S, Dragoni C, et al. Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/ DM-2). Neuromuscul Disord 2003; 13: 813-21.
38. Miller JW, Urbinati CR, Teng-Umnuay P, Stenberg MG, Byrne BJ, Thornton CA, et al. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 2000; 19: 4439-48.
39. Minnerop M, Weber B, Schoene-Bake JC, Roeske S, Mirbach S, Anspach C, et al. The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease. Brain 2011; 134 (Pt 12): 3530-46.
40. Miyazaki Y, Adachi H, Katsuno M, Minamiyama M, Jiang YM, Huang Z, et al. Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2. Nat Med 2012; 18: 1136-41.
41. Modoni A, Silvestri G, Pomponi MG, Mangiola F, Tonali PA, Marra C. Characterization of the pattern of cognitive impairment in myotonic dystrophy type 1. Arch Neurol 2004; 61: 1943-7.
42. Ono S, Takahashi K, Jinnai K, Kanda F, Fukuoka Y, Kurisaki H, et al. Loss of serotonin-containing neurons in the raphe of patients with myotonic dystrophy: a quantitative immunohistochemical study and relation to hypersomnia. Neurology 1998a; 50: 535-8.
43. Ono S, Takahashi K, Jinnai K, Kanda F, Fukuoka Y, Kurisaki H, et al. Loss of catecholaminergic neurons in the medullary reticular formation in myotonic dystrophy. Neurology 1998b; 51: 1121-4.
44. Orengo JP, Chambon P, Metzger D, Mosier DR, Snipes GJ, Cooper TA. Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy. Proc Natl Acad Sci USA 2008; 105: 2646-51.
45. Osborne RJ, Lin X, Welle S, Sobczak K, O'Rourke JR, Swanson MS, et al. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum Mol Genet 2009; 18: 1471-81.
46. Panaite PA, Gantelet E, Kraftsik R, Gourdon G, Kuntzer T, Barakat-Walter I. Myotonic dystrophy transgenic mice exhibit pathologic abnormalities in diaphragm neuromuscular junctions and phrenic nerves. J Neuropathol Exp Neurol 2008; 67: 763-72.
47. Perbellini R, Greco S, Sarra-Ferraris G, Cardani R, Capogrossi MC, Meola G, et al. Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1. Neuromuscul Disord 2011; 21: 81-8.
48. Ranum LP, Cooper TA. RNA-mediated neuromuscular disorders. Annu Rev Neurosci 2006; 29: 259-77.
49. Rau F, Freyermuth F, Fugier C, Villemin JP, Fischer MC, Jost B, et al. Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy. Nat Struct Mol Biol 2011; 18: 840-5.
50. Robbins TW, Arnsten AF. The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 2009; 32: 267-87.
51. Romeo V, Pegoraro E, Squarzanti F, Soraru G, Ferrati C, Ermani M, et al. Retrospective study on PET-SPECT imaging in a large cohort of myotonic dystrophy type 1 patients. Neurol Sci 2010; 31: 757-63.
52. Rosahl TW, Geppert M, Spillane D, Herz J, Hammer RE, Malenka RC, et al. Short-term synaptic plasticity is altered in mice lacking synapsin I. Cell 1993; 75: 661-70.
53. Savkur RS, Philips AV, Cooper TA. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 2001; 29: 40-7.
54. Schluter OM, Khvotchev M, Jahn R, Sudhof TC. Localization versus function of Rab3 proteins. Evidence for a common regulatory role in controlling fusion. J Biol Chem 2002; 277: 40919-29.
55. Schweizer MC, Henniger MS, Sillaber I. Chronic mild stress (CMS) in mice: of anhedonia, 'anomalous anxiolysis' and activity. PLoS One 2009; 4: e4326.
56. Sergeant N, Bombois S, Ghestem A, Drobecq H, Kostanjevecki V, Missiaen C, et al. Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach. J Neurochem 2003; 85: 1581-91.
57. Seznec H, Agbulut O, Sergeant N, Savouret C, Ghestem A, Tabti N, et al. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum Mol Genet 2001; 10: 2717-26.
58. Seznec H, Lia-Baldini AS, Duros C, Fouquet C, Lacroix C, Hofmann-Radvanyi H, et al. Transgenic mice carrying large human genomic sequences with expanded CTG repeat mimic closely the DM CTG repeat intergenerational and somatic instability. Hum Mol Genet 2000; 9: 1185-94.
59. Sistiaga A, Urreta I, Jodar M, Cobo AM, Emparanza J, Otaegui D, et al. Cognitive/personality pattern and triplet expansion size in adult myotonic dystrophy type 1 (DM1): CTG repeats, cognition and personality in DM1. Psychol Med 2010; 40: 487-95.
60. Steidl EM, Neveu E, Bertrand D, Buisson B. The adult rat hippocampal slice revisited with multi-electrode arrays. Brain Res 2006; 1096: 70-84.
61. Sudhof TC. The synaptic vesicle cycle. Annu Rev Neurosci 2004; 27: 509-47.
62. Suenaga K, Lee KY, Nakamori M, Tatsumi Y, Takahashi MP, Fujimura H, et al. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain. PLoS One 2012; 7: e33218.
63. Sugita S. Human growth hormone co-transfection assay to study molecular mechanisms of neurosecretion in PC12 cells. Methods 2004; 33: 267-72.
64. Tallent MK, Varghis N, Skorobogatko Y, Hernandez-Cuebas L, Whelan K, Vocadlo DJ, et al. In vivo modulation of O-GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation. J Biol Chem 2009; 284: 174-81.
65. Timchenko NA, Cai ZJ, Welm AL, Reddy S, Ashizawa T, Timchenko LT. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J Biol Chem 2001; 276: 7820-6.
66. Wang GS, Kearney DL, De Biasi M, Taffet G, Cooper TA. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy. J Clin Invest 2007; 117: 2802-11.
67. Wang X, Wang Q, Yang S, Bucan M, Rich MM, Engisch KL. Impaired activity-dependent plasticity of quantal amplitude at the neuromuscular junction of Rab3A deletion and Rab3A earlybird mutant mice. J Neurosci 2011; 31: 3580-8.
68. Weber YG, Roebling R, Kassubek J, Hoffmann S, Rosenbohm A, Wolf M, et al. Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2. Neurology 2010; 74: 1108-17.
69. Werner FM, Covenas R. Classical neurotransmitters and neuropeptides involved in major depression: a review. Int J Neurosci 2010; 120: 455-70.
70. Winblad S, Lindberg C, Hansen S. Temperament and character in patients with classical myotonic dystrophy type 1 (DM-1). Neuromuscul Disord 2005; 15: 287-92.